(1)
Mild Clinical Course of COVID-19 Infection in Chronic Myeloid Leukemia (CML) Patients Receiving Tyrosine Kinase Inhibitors (TKIs) Without Interruption. Mediterr J Hematol Infect Dis 2021, 13 (1), e2021022. https://doi.org/10.4084/mjhid.2021.022.